Last reviewed · How we verify

NCT03937180: Big Bird

Blended Care for the Discontinuation of Benzodiazepine Use

Completed NA Last updated 15 July 2022
What this trial tests

NA trial testing Blended care in Benzodiazepine Dependence in 924 participants. Completed in 2 August 2021.

Timeline
24 June 2019
Primary endpoint
30 July 2021
2 August 2021

Quick facts

Lead sponsorKristien Coteur
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment924
Start date24 June 2019
Primary completion30 July 2021
Estimated completion2 August 2021
Sites110 locations across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

Kristien Coteur

Who can join

18 and older, any sex, with Benzodiazepine Dependence or Benzodiazepine Dependent. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to compare two strategies performed by GPs to help patients taking benzodiazepines on a daily basis for at least six months to discontinue their use. The first strategy consists of the usual or standard support provided by the GP, which often starts with a discontinuation advice or letter, the second is blended support where face-to-face consultations with the GP are alternated with web-based self-learning by the patient.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Blended care to discontinue benzodiazepine receptor agonists use in patients with chronic insomnia disorder: a pragmatic cluster randomized controlled trial in primary care.
    Coteur K, Henrard G, Schoenmakers B, Laenen A, et al · · 2023 · cited 13× · PMID 36413221 · DOI 10.1093/sleep/zsac278
  2. Effectiveness of a blended care programme for the discontinuation of benzodiazepine use for sleeping problems in primary care: study protocol of a cluster randomised trial, the Big Bird trial.
    Coteur K, Van Nuland M, Vanmeerbeek M, Henrard G, et al · · 2020 · cited 6× · PMID 32075832 · DOI 10.1136/bmjopen-2019-033688
  3. Implementing Blended Care to Discontinue Benzodiazepine Receptor Agonist Use for Insomnia: Process Evaluation of a Pragmatic Cluster Randomized Controlled Trial.
    Coteur K, Van Nuland M, Schoenmakers B, Anthierens S, et al · · 2023 · cited 5× · PMID 37027198 · DOI 10.2196/43738
  4. Fostering clinical research in general practice and family medicine. Selected abstracts from the 93rd EGPRN conference Halle, Germany, 14–17 October 2021 : All abstracts of the conference can be found at the EGPRN website https://www.egprn.org/page/conference-abstracts
    · 2023

Verify or expand the search:

Other recruiting trials for Benzodiazepine Dependence

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03937180.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing